Nebula Research & Development’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Other funds holding HCA
Nebula Research & Development's HCA Position: Q4 2023 in Review
Nebula Research & Development sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 3,929 shares — an estimated $966K sold.
Nebula Research & Development first reported a position in HCA in Q3 2023 and held it in 1 quarter. The position peaked at $966K in Q3 2023. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.
- Nebula Research & Development reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
- Nebula Research & Development sold 3,929 HCA Healthcare shares in Q4 2023, an estimated $966K.
- Nebula Research & Development first reported a position in HCA Healthcare in Q3 2023 and held it in 1 quarter.
- Nebula Research & Development's HCA Healthcare position peaked at $966K in Q3 2023.
- 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.
Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.